source
- STAT+: MIT says research has fallen 10%, and grad student enrollment is downAt MIT, research has shrunk 10% from a year ago, and the school expects a persistent drop in graduate admissions.STAT · 2mo ago↗ source
- Perioperative Durvalumab Plus Neoadjuvant EV Displays EFS, OS Benefits vs SOC in MIBCPerioperative durvalumab plus EV showed positive topline efficacy findings in MIBC.onclive · 2mo ago↗ source
- Rintatolimod Plus Pembrolizumab and Cisplatin Displays 50% ORR in Recurrent Ovarian CancerThe addition of rintatolimod to pembrolizumab and cisplatin demonstrated robust albeit preliminary antitumor activity in patients with recurrent ovarian cancer.onclive · 2mo ago↗ source